Diflucan and Nadolol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diflucan (fluconazole) and Nadolol (nadolol). Common drug interactions include abdominal pain among females and agranulocytosis among males.

The phase IV clinical study analyzes what interactions people have when they take Diflucan and Nadolol. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Diflucan?

Diflucan has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 28,471 Diflucan users. Check the latest studies of Diflucan.

What is Nadolol?

Nadolol has active ingredients of nadolol. It is often used in high blood pressure. eHealthMe is studying from 4,476 Nadolol users. Check the latest studies of Nadolol.

On Jul, 05, 2026

61 people who take Diflucan and Nadolol together, and have interactions are studied.

What are the common drug interactions of Diflucan and Nadolol, by gender? *:

female:

Abdominal pain
Anaemia (lack of blood)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Colitis (inflammation of colon)
Colitis ulcerative (inflammation of colon with ulcer)
Constipation
Drug ineffective
Erythema (redness of the skin)
Female genital tract fistula (passage in genital tract of female)
Frequent bowel movements

male:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Blood glucose fluctuation
Blood phosphorus decreased
Bone disorder
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Diflucan and Nadolol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease

40-49:

Glossitis (infection of tongue with soreness)
Oral candidiasis (fungal infection of mouth)
Pharyngolaryngeal pain

50-59:

Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
Aphthous stomatitis (mouth ulcer)
Arteriosclerosis (thickening and hardening of arteries)
Asthma
Back pain
Blood creatine phosphokinase increased
Blood creatine phosphokinase mb increased
Blood glucose fluctuation
Blood phosphorus decreased
Bone disorder

60+:

Nausea (feeling of having an urge to vomit)
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Colitis (inflammation of colon)
Colitis ulcerative (inflammation of colon with ulcer)
Drug ineffective
Erythema (redness of the skin)
Female genital tract fistula (passage in genital tract of female)
Frequent bowel movements
Haematochezia (passage of stools containing blood)
Headache (pain in head)

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 36 people, 59.02%
Colitis (inflammation of colon): 35 people, 57.38%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 29 people, 47.54%
Allergies: 29 people, 47.54%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 26 people, 42.62%
Fever: 25 people, 40.98%
Oral Candidiasis (fungal infection of mouth): 17 people, 27.87%
Proctitis (inflammation of the rectum and anus): 15 people, 24.59%
Nausea (feeling of having an urge to vomit): 5 people, 8.20%
Urethral Disorder: 4 people, 6.56%

* Approximation only. Some reports may have incomplete information.

Do you take Diflucan and Nadolol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously